Near-infrared fluorescent Imaging of matrix metalloproteinase activity after myocardial infarction

被引:170
作者
Chen, JQ
Tung, CH
Allport, JR
Chen, S
Weissleder, R
Huang, PL
机构
[1] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA
[2] Massachusetts Gen Hosp, Div Cardiol, Charlestown, MA USA
[3] Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA
[4] Harvard Univ, Sch Med, Charlestown, MA USA
关键词
matrix metalloproteinases; myocardial infarction; imaging; gelatinase; remodeling;
D O I
10.1161/01.CIR.0000160936.91849.9F
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-We used a molecular probe activated by protease cleavage to image expression of matrix metalloproteinases ( MMPs) in the heart after myocardial infarction. Methods and Results-We synthesized and characterized a near-infrared fluorescent (NIRF) probe that is activated by proteolytic cleavage by MMP2 and MMP9. The NIRF probe was injected into mice at various time points up to 4 weeks after myocardial infarction induced by ligation of the left anterior descending coronary artery. NIRF imaging of MMP activity increased in the infarct region, with maximal expression at 1 to 2 weeks, persisting to 4 weeks. Zymography and real-time polymerase chain reaction analysis showed that MMP9 expression is increased at 2 to 4 days, and MMP2 expression is increased at 1 to 2 weeks. Dual-label confocal microscopy showed colocalization of NIRF imaging with neutrophils on day 2, and flow cytometric analysis confirmed that NIRF signal is associated with leukocytes in the infarct zone. Conclusions-This study demonstrates that the activity of MMPs in the myocardium may be imaged by use of specific activity-dependent molecular probes.
引用
收藏
页码:1800 / 1805
页数:6
相关论文
共 39 条
  • [1] Progressive heart failure after myocardial infarction in mice
    Bayat, H
    Swaney, JS
    Ander, AN
    Dalton, N
    Kennedy, BP
    Hammond, HK
    Roth, DM
    [J]. BASIC RESEARCH IN CARDIOLOGY, 2002, 97 (03) : 206 - 213
  • [2] In vivo molecular target assessment of matrix metalloproteinase inhibition
    Bremer, C
    Tung, CH
    Weissleder, R
    [J]. NATURE MEDICINE, 2001, 7 (06) : 743 - 748
  • [3] Molecular imaging of MMP expression and therapeutic MMP inhibition
    Bremer, C
    Tung, CH
    Weissleder, R
    [J]. ACADEMIC RADIOLOGY, 2002, 9 : S314 - S315
  • [4] Effects of chronic treatment with L-arginine on atherosclerosis in ApoE knockout and ApoE/inducible NO synthase double-knockout mice
    Chen, JQ
    Kuhlencordt, P
    Urano, F
    Ichinose, H
    Astern, J
    Huang, PL
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (01) : 97 - 103
  • [5] In vivo imaging of proteolytic activity in atherosclerosis
    Chen, JQ
    Tung, CH
    Mahmood, U
    Ntziachristos, V
    Gyurko, R
    Fishman, MC
    Huang, PL
    Weissleder, R
    [J]. CIRCULATION, 2002, 105 (23) : 2766 - 2771
  • [6] Danielsen CC, 1998, J MOL CELL CARDIOL, V30, P1431
  • [7] Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
    Ducharme, A
    Frantz, S
    Aikawa, M
    Rabkin, E
    Lindsey, M
    Rohde, LE
    Schoen, FJ
    Kelly, RA
    Werb, Z
    Libby, P
    Lee, RT
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (01) : 55 - 62
  • [8] Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction
    Fernandez-Patron, C
    Stewart, KG
    Zhang, YL
    Koivunen, E
    Radomski, MW
    Davidge, ST
    [J]. CIRCULATION RESEARCH, 2000, 87 (08) : 670 - 676
  • [9] Fernandez-Patron C, 1999, CIRC RES, V85, P906
  • [10] Differential regulation of platelet aggregation by matrix metalloproteinases-9 and-2
    Fernandez-Patron, C
    Martinez-Cuesta, MA
    Salas, E
    Sawicki, G
    Wozniak, M
    Radomski, MW
    Davidge, ST
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, 82 (06) : 1730 - 1735